IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
KIAA0226L | KIAA0226-like | | | | | | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes
| | | | | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
P2RY10 | Purinergic receptor P2Y, G-protein coupled, 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PASK | PAS domain containing serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
PDCD1 | Programmed cell death 1 | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
PTPN7 | Protein tyrosine phosphatase, non-receptor type 7 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | | | | Tissue enhanced |
PVRIG | Poliovirus receptor related immunoglobulin domain containing | Predicted membrane proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | RAS pathway related proteins
| | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
SHOX2 | Short stature homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
SLAMF1 | Signaling lymphocytic activation molecule family member 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SP140 | SP140 nuclear body protein | Transcription factors
| | | | | Tissue enhanced |
STAP1 | Signal transducing adaptor family member 1 | | | | | | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
THEMIS | Thymocyte selection associated | | | | | | Tissue enhanced |
TNFSF11 | Tumor necrosis factor (ligand) superfamily, member 11 | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TRAT1 | T cell receptor associated transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
TREML1 | Triggering receptor expressed on myeloid cells-like 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
VPREB3 | Pre-B lymphocyte 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Tissue enhanced |